InsiderTradr

Aptus Pharma Limited (APPL.BO)

BSE · INR · Healthcare · Medical Distribution

₹472.10 (-1.99%) as of

Key statistics

Market cap
8.10B
P/E (TTM)
101.75
EPS (TTM)
4.64
Dividend yield
0.00%
52-week range
49.24 – 510.90
Revenue (TTM)
811.17M
Profit margin
9.80%
Volume
11.60k

About Aptus Pharma Limited

Aptus Pharma Limited engages in the marketing and distribution of finished pharmaceutical formulations. The company operates through four divisions: Aptus Pharma, Pioneer division, which includes marketing of acute therapies including general anti-infectives, pain management, antacids, and gastrointestinal drugs; Aptus CD Care, Cardiac Diabetic division, which includes marketing of chronic therapies, including antihypertensive, anti-diabetic, and lipid-lowering; Aptus Wellcare offers wellness and nutraceutical products, over-the-counter (OTC) formulations, and personal care products; and Aptus Global, export division engages in exploring and developing opportunities in overseas markets, semi-regulated and emerging countries. It also offers anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, antidiabetic, lipid-lowering, and general wellness products. In additio, the company develops and markets skin care, face care, hair care, personal hygiene, wellness, and self-care over-the-counter products. Its products are available in balms, capsules, drops, gels, injections, lotions, ointments, powders, sachets, softgels, solutions, suspensions, syrups, tablets, and vials. It distributes the products through clearing and forwarding agents. Aptus Pharma Limited was incorporated in 2010 and is headquartered in Rajkot, India.

Sector
Healthcare
Industry
Medical Distribution
Headquarters
Rajkot, India
Employees
91

aptus-pharma.com

Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.

Related stocks